Lymphocyte Subsets in a Large Cohort of Patients with Systemic Lupus Erythematosus

Lupus

Volumn 2, Issue 4, 1993, Pages 227-231

  Erkeller Yüksel, Feza ^a   Hulstaart, Frank ^b   Hannet, Irene ^b   Isenberg, David ^a   Lydyard, Peter ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ICS ^*  (United Kingdom)

Author keywords

Lymphocyte subsets; NK cells; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTE SUBSETS; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTE SUBSETS;

EID: 0027484294     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/096120339300200404     Document Type: Article

References (27)

1. Worral JG, Snaith ML, Batchelor JR, Isenberg DA SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Quart J Med 1990; 275: 319-30.
2. Isenberg DA, Colaco BC, Dudeney C., Todd-Pokropek A., Snaith ML A study of the relationship between anti DNA antibody idiotypes and anticardiolipin antibodies with disease activity in systemic lupus erythematosus. Medicine (Baltimore) 1986; 66: 46-55.
3. Gonzalez-Amaro R., Alocer-Varela J., Alarcon-Segonovia D. Natural killer cell activity in the systemic connective tissue diseases. J Rheumatol 1988; 15: 1223-8.
4. Toth J., Starsia Z., Buc M., Stefanovic J. Family study of natural killer cell activity in Clq-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and Clq deficiency. Immunobiology 1989; 180: 47-54.
5. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
6. Tan EM, Cohen AS, Fries JC et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1983; 25: 1271-7.
7. Isenberg DA, Shonfeld Y., Schwartz RS Multiple serological reactions and their relationship to clinical activity in systemic lupus erythematosus; a study of 56 patients. Arthritis Rheum 1984; 27: 132-8.
8. Reichert T., DeBruyere M., Deneys V. et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991; 60: 190-208.
9. Raziuddin S., Danial HB, Kelley M. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expression. Clin Immunol Immunopathol 1988; 48: 42-49.
10. Morimoto C., Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 1980; 66: 1171-4.
11. Smolen JS, Chused TM, Leiserson WM, Reeves Jjp, Alling D., Steinberg AD Heterogeneity of immunoregulatory T cell subsets in systemic lupus erythematosus. Correlation with clinical features. J Am J Med 1982; 72: 783-90.
12. Delfraissy JF, Segond P., Galanaud P., Wallon C., Masias P., Dormont J. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. Clin Invest 1980; 66: 141-8.
13. McInersey MF, Clough JD, Senitzer D., Cathcart MK Two distinct subsets of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1988; 49: 116-32.
14. Morimoto C., Steinberg AD, Letwin NL et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demostrated with anti-2H4 antibody. J Clin Invest 1987; 79: 762-8.
15. Takeuchi T., Tanaka S., Steiberg AD, Matsuyama T., Schlossman SF, Morimoto C. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. J Clin Invest 1988; 82: 1288-94.
16. Tanaka S., Matsuyama T., Steinberg AD, Schlossman SF, Morimoto C. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 398-405.
17. Gorla R., Airo P., Franceschini F. et al. Decreased number of peripheral blood CD4+CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1048-53.
18. Reme T., Portier M., Frayssinoux F. et al. T cell receptor expression and activation of synovial lymhocyte subsets in patients with rheumatoid arthritis. Arthritis Rheum 1990; 33: 485-91.
19. Magyarlaki, T., Losonczy H., Par A. Comparison of some lymphocyte markers in B cell chronic lymphocytic leukaemia and systemic lupus erythematosus (the B lymphocyte subset). Haematologia-Budap 1990; 23: 110-20.
20. Kumagai S., Ishida H., Iwai K. et al. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells. Clin Exp Immunol 1989; 78: 348-53.
21. Herberman RB, Whiteside TL The role of natural killer cells in human disease. Clin Immunol Immunopathol 1989; 53: 1-23.
22. Fitzgerald PA, Mendelson M., Lopez C. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. J Immunol 1985; 134: 2666-72.
23. Ortaldo JR, Oldham RK, Cannon GC, Herberman RB Specificity of natural cytotoxic reactivity of normal human lymphocyts against a myeloid leukemia cell line. J Natl Cancer Inst (USA) 1977; 59: 77-82.
24. Garcia-Penarrubbia P., Koster FT, Kelley RO, McDowell TD, Bankhurst AD Antibacterial activity of human natural killer cells. J Exp Med 1989; 169: 99-113.
25. Ginzler EM, Schorn K. Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 67-78.
26. Ter-Borg EJ, Horst G., Limburg PC, van Rijwijk MH, Kallenberg CG C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990; 17: 1642-8.
27. DeLuis A., Pigrau C., Pahissa A., Fernandez F., Martinez- Vazquez JM Infection in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 1990; 94: 607-10.